[1] Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, et al. Carbapenemase-producing organisms: a global scourge. Clin Infect Dis 2018;66:1290–7.
[2] Pailhoriès H, Hadjadj L, Mahieu R, Crochette N, Rolain JM, Kempf M. Fortuitous diagnosis of NDM-1-producing Acinetobacter pittii carriage in a patient from France with no recent history of travel. J Antimicrob Chemother 2017;72:942–4.
[3] Roca I, Mosqueda N, Altun B, Espinal P, Akova M, Vila J. Molecular characterization of NDM-1-producing Acinetobacter pittii isolated from Turkey in 2006. J Antimicrob Chemother 2014;69:3437–8.
[4] Yang J, Chen Y, Jia X, Luo Y, Song Q, Zhao W, et al. Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clin Microbiol Infect 2012;18:E506–13.
[5] La Scola B, Gundi VA, Khamis A, Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol 2006;44:827–32.
[6] Mammeri H, Poirel L, Mangeney N, Nordmann P. Chromosomal integration of a cephalosporinase gene from Acinetobacter baumanniiinto Oligella urethralis as a source of acquired resistance to beta-lactams. Antimicrob Agents Chemother 2003;47:1536–42.
[7] CLSI. Performance Standards for Antimicrobial Susceptibility Testing: Supple- ment M100 (28th ed.). Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2018.
[8] Nagano N, Endoh Y, Nagano Y, Toyama M, Matsui M, Shibayama K, et al. First report of OXA-48 carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Japan from a patient returned from Southeast Asia. Jpn J Infect Dis 2013;66:79–81.
[9] Coil D, Jospin G, Darling AE. A5-miseq: an updated pipeline to assemble microbial genomes from Illumina MiSeq data. Bioinformatics 2015;31:587–9.
[10] Zhang Y, Zhou S. Draft genome sequence of an NDM-1-, OXA-421- and AmpC- producing Acinetobacter pittii ST220 in Anhui Province, China. J Glob Antimicrob Resist 2018;14:176–7.
[11] Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 2012;67:2640–4.
[12] Carattoli A, Zankari E, García-Fernández A, Larsen MV, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 2014;58:3895– 903.
[13] Leong CG, Bloomfield RA, Boyd CA, Dornbusch AJ, Lieber L, Liu F, et al. The role of core and accessory type IV pilus genes in natural transformation and twitching motility in the bacterium Acinetobacter baylyi. PLoS One 2017;12: e0182139.
[14] Nakazawa Y, Ii R, Tamura T, Hoshina T, Tamura K, Kawano S, et al. A case of NDM-1-producing Acinetobacter baumannii transferred from India to Japan. J Infect Chemother 2013;19:330–2.
[15] De Geyter D, Blommaert L, Verbraeken N, Sevenois M, Huyghens L, Martini H, et al. The sink as a potential source of transmission of carbapenemase- producing Enterobacteriaceae in the intensive care unit. Antimicrob Resist Infect Control 2017;6:24.
[16] Kotay S, Chai W, Guilford W, Barry K, Mathers AJ. Spread from the sink to the patient: in situ study using green fluorescent protein (GFP)-expressing Escherichia coli to model bacterial dispersion from hand-washing sink-trap reservoirs. Appl Environ Microbiol 2017;83:pii:e03327–16.
[17] Yang CH, Su PW, Moi SH, Chuang LY. Biofilm formation in Acinetobacter baumannii: genotype-phenotype correlation. Molecules 2019;24:pii:E1849.
[18] Bravo Z, Chapartegui-González I, Lázaro-Díez M, Ramos-Vivas J. Acinetobacter pittii biofilm formation on inanimate surfaces after long-term desiccation. J Hosp Infect 2018;98:74–82.
[19] Jain AL, Harding CM, Assani K, Shrestha CL, Haga M, Leber A, et al. Characteristics of invasive Acinetobacter species isolates recovered in a pediatric academic center. BMC Infect Dis 2016;16:346.